AJP - Endocrinology and Metabolism, Vol 267, Issue 1 E95-101, Copyright © 1994 by American Physiological Society

ARTICLES

Lipid abnormalities in tissues of the KKAy mouse: effects of pioglitazone on malonyl-CoA and diacylglycerol

A. K. Saha, T. G. Kurowski, J. R. Colca and N. B. Ruderman
Diabetes and Metabolism Unit, Boston University Medical Center, Massachusetts 02118.

Insulin resistance is present in liver and muscle of subjects with type 2 diabetes and obesity. Recent studies suggest that such insulin resistance could be related to abnormalities in lipid-mediated signal transduction; however, the nature of these abnormalities is unclear. To examine this question further, tissue levels of diacylglycerol (DAG), malonyl-CoA, and triglyceride (TG) were determined in liver and soleus muscle of obese insulin-resistant KKAy mice and lean C57 BL control mice. In addition, the effects of treatment with pioglitazone, an antidiabetic agent that acts by increasing insulin sensitivity in muscle, liver, and other tissues, were assessed. The KKAy mice were hyperglycemic (407 vs. 138 mg/dl), hypertriglyceridemic (337 vs. 109 mg/dl), hyperinsulinemic (631 vs. 15 mU/ml), and weighed more (42 vs. 35 g) than the control mice. They also had 1.5- to 2.0-fold higher levels of malonyl-CoA in both liver and muscle, higher DAG (twofold) and TG (1.3-fold) levels in muscle, and higher TG (threefold), but not DAG, levels. Treatment of the KKAy mice with pioglitazone for 4 days decreased plasma glucose, TGs, and insulin by approximately 50% and restored hepatic and muscle malonyl-CoA levels to control values. In contrast, pioglitazone increased hepatic and muscle DAG levels two- or threefold. It has no effect on muscle or hepatic TG content, and it slightly increased hepatic TGs in the control group. The results indicate that abnormalities in tissue lipids occur in both liver and muscle of the KKAy mouse and that they are differentially altered when insulin sensitivity is enhanced by treatment with pioglitazone.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				J. E. Kuhl, N. B. Ruderman, N. Musi, L. J. Goodyear, M. E. Patti, S. Crunkhorn, D. Dronamraju, A. Thorell, J. Nygren, O. Ljungkvist, et al. Exercise training decreases the concentration of malonyl-CoA and increases the expression and activity of malonyl-CoA decarboxylase in human muscle Am J Physiol Endocrinol Metab, June 1, 2006; 290(6): E1296 - E1303. [Abstract] [Full Text] [PDF]

				A. Beha, H.-P. Juretschke, J. Kuhlmann, C. Neumann-Haefelin, U. Belz, M. Gerl, W. Kramer, M. Roden, and A. W. Herling Muscle type-specific fatty acid metabolism in insulin resistance: an integrated in vivo study in Zucker diabetic fatty rats Am J Physiol Endocrinol Metab, May 1, 2006; 290(5): E989 - E997. [Abstract] [Full Text] [PDF]

				T. R. Koves, R. C. Noland, A. L. Bates, S. T. Henes, D. M. Muoio, and R. N. Cortright Subsarcolemmal and intermyofibrillar mitochondria play distinct roles in regulating skeletal muscle fatty acid metabolism Am J Physiol Cell Physiol, May 1, 2005; 288(5): C1074 - C1082. [Abstract] [Full Text] [PDF]

				J. R. Colca, W. G. McDonald, D. J. Waldon, J. W. Leone, J. M. Lull, C. A. Bannow, E. T. Lund, and W. R. Mathews Identification of a novel mitochondrial protein ("mitoNEET") cross-linked specifically by a thiazolidinedione photoprobe Am J Physiol Endocrinol Metab, February 1, 2004; 286(2): E252 - E260. [Abstract] [Full Text] [PDF]

				M. A. Iglesias, J.-M. Ye, G. Frangioudakis, A. K. Saha, E. Tomas, N. B. Ruderman, G. J. Cooney, and E. W. Kraegen AICAR Administration Causes an Apparent Enhancement of Muscle and Liver Insulin Action in Insulin-Resistant High-Fat-Fed Rats Diabetes, October 1, 2002; 51(10): 2886 - 2894. [Abstract] [Full Text] [PDF]

				J. Franch, J. Knudsen, B. A. Ellis, P. K. Pedersen, G. J. Cooney, and J. Jensen Acyl-CoA Binding Protein Expression Is Fiber Type- Specific and Elevated in Muscles From the Obese Insulin-Resistant Zucker Rat Diabetes, February 1, 2002; 51(2): 449 - 454. [Abstract] [Full Text] [PDF]

				R. Lau, W. D. Blinn, A. Bonen, and D. J. Dyck Stimulatory effects of leptin and muscle contraction on fatty acid metabolism are not additive Am J Physiol Endocrinol Metab, July 1, 2001; 281(1): E122 - E129. [Abstract] [Full Text] [PDF]

				R. L. Dobbins, L. S. Szczepaniak, B. Bentley, V. Esser, J. Myhill, and J. D. McGarry Prolonged Inhibition of Muscle Carnitine Palmitoyltransferase-1 Promotes Intramyocellular Lipid Accumulation and Insulin Resistance in Rats Diabetes, January 1, 2001; 50(1): 123 - 130. [Abstract] [Full Text]

				D. Chien, D. Dean, A. K. Saha, J. P. Flatt, and N. B. Ruderman Malonyl-CoA content and fatty acid oxidation in rat muscle and liver in vivo Am J Physiol Endocrinol Metab, August 1, 2000; 279(2): E259 - E265. [Abstract] [Full Text] [PDF]

				D. R. Laybutt, C. Schmitz-Peiffer, A. K. Saha, N. B. Ruderman, T. J. Biden, and E. W. Kraegen Muscle lipid accumulation and protein kinase C activation in the insulin-resistant chronically glucose-infused rat Am J Physiol Endocrinol Metab, December 1, 1999; 277(6): E1070 - E1076. [Abstract] [Full Text] [PDF]

				S. D Clarke, P. Thuillier, R. A Baillie, and X. Sha Peroxisome proliferator-activated receptors: a family of lipid-activated transcription factors Am. J. Clinical Nutrition, October 1, 1999; 70(4): 566 - 571. [Abstract] [Full Text] [PDF]

				A. K. Saha, D. R. Laybutt, D. Dean, D. Vavvas, E. Sebokova, B. Ellis, I. Klimes, E. W. Kraegen, E. Shafrir, and N. B. Ruderman Cytosolic citrate and malonyl-CoA regulation in rat muscle in vivo Am J Physiol Endocrinol Metab, June 1, 1999; 276(6): E1030 - E1037. [Abstract] [Full Text] [PDF]

				N. B. Ruderman, A. K. Saha, D. Vavvas, and L. A. Witters Malonyl-CoA, fuel sensing, and insulin resistance Am J Physiol Endocrinol Metab, January 1, 1999; 276(1): E1 - E18. [Abstract] [Full Text] [PDF]

				K. Motojima, P. Passilly, J. M. Peters, F. J. Gonzalez, and N. Latruffe Expression of Putative Fatty Acid Transporter Genes Are Regulated by Peroxisome Proliferator-activated Receptor alpha  and gamma  Activators in a Tissue- and Inducer-specific Manner J. Biol. Chem., July 3, 1998; 273(27): 16710 - 16714. [Abstract] [Full Text] [PDF]

				C. Schmitz-Peiffer, N. D. Oakes, C. L. Browne, E. W. Kraegen, and T. J. Biden Reversal of chronic alterations of skeletal muscle protein kinase C from fat-fed rats by BRL-49653 Am J Physiol Endocrinol Metab, November 1, 1997; 273(5): E915 - E921. [Abstract] [Full Text] [PDF]

				F. Assimacopoulos-Jeannet, S. Thumelin, E. Roche, V. Esser, J. D. McGarry, and M. Prentki Fatty Acids Rapidly Induce the Carnitine Palmitoyltransferase I Gene in the Pancreatic beta -Cell Line INS-1 J. Biol. Chem., January 17, 1997; 272(3): 1659 - 1664. [Abstract] [Full Text] [PDF]

				A. K. Saha, A. J. Schwarsin, R. Roduit, F. Masse, V. Kaushik, K. Tornheim, M. Prentki, and N. B. Ruderman Activation of Malonyl-CoA Decarboxylase in Rat Skeletal Muscle by Contraction and the AMP-activated Protein Kinase Activator 5-Aminoimidazole-4-carboxamide-1-beta -D-ribofuranoside J. Biol. Chem., August 4, 2000; 275(32): 24279 - 24283. [Abstract] [Full Text] [PDF]